Asthma as a Comorbid Disease in COVID-19
Yükleniyor...
Dosyalar
Tarih
2020
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
BILIMSEL TIP YAYINEVI
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel coronavirus that causes coronavirus disease 2019 (COVID-19). In terms of asthma and COVID-19, there is also a risk of experiencing an asthma exacerbation triggered by coronavirus infection beyond the direct risk of the infection itself. As a comorbid disease, the prevalence of COVID-19 infection in asthma patients is not clear. In addition, the influence of asthma on the severity of COVID-19 has not been reported. The aim of this review was to summarize the reported worldwide data about the prevalence and the clinical characteristics of patients with asthma during COVID-19 infection.
Açıklama
Bavbek, Sevim/0000-0002-7884-0830
Anahtar Kelimeler
Asthma, severe asthma, asthma attack, viral infection, coronavirus disease 2019, COVID-19, SARS-CoV-2
Kaynak
ASTIM ALLERJI IMMUNOLOJI
WoS Q Değeri
N/A
Scopus Q Değeri
Q4
Cilt
18
Sayı
Künye
Baççıoğlu, A., & Bavbek, S. (2020). Asthma as A Comorbid Disease in COVID-19. Asthma Allergy Immunology. 18(1), 1-7.
